In just five years, AI has advanced from preschool-level capabilities to systems that can reason and act with the skill of an undergraduate. Proof of concepts are emerging across industries—from ...

Eyam claims its AI drug discovery and delivery platform can develop treatment at less than half the usual cost.

But three of those FDA employees told CNN that Elsa just makes up nonexistent studies, something commonly referred to in AI ...

Clinical trials remain the cornerstone of evidence-based medicine, yet they are frequently protracted and costly. More often than commonly thought, clinical trials are also uninformative.1 Artificial ...

Answer ALS is proud to announce the launch of a groundbreaking collaborative initiative aimed at accelerating AI-powered drug ...

It’s a sentiment felt widely across the medical field as AI starts to touch nearly every corner of medical research, physician training and processes, and patient care. The rollout of AI across health ...

General Catalyst and Square Peg led the $150 million financing round with participation from NVentures, NVIDIA’s venture ...

A Stanford-led study found that most AI chatbots have stopped including medical disclaimers in health responses, raising concerns that users might trust potentially unsafe or unverified advice.

The major LLMs today are legal landmines, providing no visibility into training data that may violate copyrights, patents, ...

New research from the Wharton School’s Generative  AI Labs shows how large language models can be coaxed into ignoring safety ...

Once cautious, OpenAI, Grok, and others will now dive into giving unverified medical advice with virtually no disclaimers.

Unlike Elon Musk's brain-computer interface, Synchron's doesn't require open-skull surgery, and it has an OpenAI chatbot ...